New daily weight-loss pill shows success at clinical trial
SMRTR summary
The new oral weight-loss drug orforglipron demonstrated significant results in a large trial, with participants losing an average of 16 pounds over 9 months and showing improved blood sugar levels, potentially rivaling popular weight-loss injections.
SMRTR provides this summary for quick context. The original article belongs to The Guardian.
Read the original article